Open AccessThrombotic Thrombocytopenic Purpura in an Asplenic Patient with Hereditary Spherocytosis
Author(s) -
David L. Becton,
Morris Kletzel,
William R. Arnold,
D. H. Berry
Publication year - 1988
Publication title -
journal of pediatric hematology/oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.388
H-Index - 78
eISSN - 1536-3678
pISSN - 1077-4114
DOI - 10.1097/00043426-198821000-00003
Subject(s) - medicine , thrombotic thrombocytopenic purpura , hereditary spherocytosis , splenectomy , plasmapheresis , spherocytosis , microangiopathic hemolytic anemia , thrombotic microangiopathy , hemolytic anemia , schistocyte , purpura (gastropod) , pediatrics , immunology , platelet , spleen , ecology , disease , antibody , biology
Thrombotic thrombocytopenic purpura (TTP) is a severe multisystem disorder characterized by microangiopathic hemolysis, central nervous system and renal dysfunction, and a very poor prognosis. Recently, however, plasma exchange or infusion therapy has proven effective in the majority of patients with TTP. We report a patient who developed TTP several years after splenectomy for hereditary spherocytosis. Despite aggressive therapy with plasmapheresis (PP), plasma infusion, antiplatelet drugs, and corticosteroids, the patient had progression of TTP that eventually resulted in his death. The occurrence of TTP in an asplenic patient with an intrinsic red cell disorder, a previously unreported association, may predict a poor prognosis.